Enliven Therapeutics, Inc. (ELVN) ownership: Top institutional holder: ORBIMED ADVISORS LLC ($312.01M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| ORBIMED ADVISORS LLC | 7959538.00 | $312.01M | 2026-03-31 |
| FMR LLC | 6829246.00 | $267.71M | 2026-03-31 |
| Polar Capital Holdings Plc | 5065933.00 | $198.58M | 2026-03-31 |
| BlackRock, Inc. | 3684707.00 | $144.44M | 2026-03-31 |
| Commodore Capital LP | 3275000.00 | $128.38M | 2026-03-31 |
| Vestal Point Capital, LP | 3250000.00 | $127.40M | 2026-03-31 |
| Bellevue Group AG | 2320867.00 | $90.98M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2168162.00 | $84.99M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-15 | |
| Sell | null | 2026-06-15 | |
| Sell | null | 2026-06-05 | |
| Sell | null | 2026-06-05 | |
| Sell | null | 2026-06-05 | |
| Sell | null | 2026-05-18 | |
| Sell | null | 2026-05-18 | |
| Sell | null | 2026-05-18 |
Back to ELVN overview · ELVN earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.